AtriCure Wins 2022 NACD Diversity, Equity, & Inclusion Award

MASON, Ohio–(BUSINESS WIRE)–AtriCure Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and post-operative pain management, today announced that it has been named a winner of the 2022 Diversity, Equity & Inclusion Award from the National Association of Corporate Directors (NACD) as the top company in the Small Cap – Public Company category. The award recognizes boards that have improved their

Leave a Reply

Your email address will not be published. Required fields are marked *